CARMELA: assessment of cardiovascular risk in seven Latin American cities |
| |
Authors: | Schargrodsky Herman Hernández-Hernández Rafael Champagne Beatriz Marcet Silva Honorio Vinueza Raúl Silva Ayçaguer Luis Carlos Touboul Pierre-Jean Boissonnet Carlos Pablo Escobedo Jorge Pellegrini Fabio Macchia Alejandro Wilson Elinor;CARMELA Study Investigators |
| |
Institution: | a Department of Cardiology, Hospital Italiano de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina b Clinical Pharmacology Unit and Hypertension Clinic, School of Medicine, Universidad Centroccidental “Lisandro Alvarado,” Decanato de Medicina, Barquisimeto, Venezuela c InterAmerican Heart Foundation, Dallas, Tex d Science and Medical Professional Development, Pfizer, Inc., New York, NY e Latin America Biometrics Center, Pfizer, Inc., New York, NY f Centro Nacional de Información de Ciencias Médicas, La Habana, Cuba g Bichet Hospital and University, Paris, France h Coronary Care Unit, Centro de Educación Médica e Investigaciones Clínicas “Norberto Quirno,” Ciudad Autónoma de Buenos Aires, Argentina i Medical Research Unit on Clinical Epidemiology, Mexican Social Security Institute, Mexico City, Mexico j Consorzio Mario Negri Sud, Chieti, Italy k Assisted Human Reproduction Canada, Ottawa, Ontario, Canada. |
| |
Abstract: | ObjectiveThis cross-sectional, population-based observational study using stratified multistage sampling assessed the prevalence of cardiovascular risk factors and carotid plaques and measured carotid intima-media thickness in individuals living in major cities in 7 Latin American countries.Patients and MethodsThe study comprised individuals (n = 11,550) aged 25 to 64 years, living in Barquisimeto, Bogota, Buenos Aires, Lima, Mexico City, Quito, and Santiago. Data on anthropometric parameters, blood pressure, fasting glucose, total and high-density lipoprotein cholesterol, triglycerides, carotid intima-media thickness, carotid plaque, and smoking status were collected through household interviews and clinical, biochemical, and sonographic measurements.ResultsThe overall prevalence rates (ranges across cities) were as follows: hypertension (≥140/90 mm Hg or pharmacologic treatment), 18% (9%-29%); hypercholesterolemia (total cholesterol ≥240 mg/dL), 14% (6%-20%); diabetes (glycemia ≥126 mg/dL or self-reported diabetes), 7% (4%-9%); metabolic syndrome, 20% (14%-27%); obesity (body mass index ≥30 kg/m2), 23% (18%-27%); smoking, 30% (22%-45%); and plaque, 8% (5%-14%). The mean intima-media thickness was 0.65 mm (0.60-0.74 mm).ConclusionThe prevalence of hypertension mirrored the world average in 3 cities but was lower in the rest. Hypercholesterolemia was highly prevalent even in countries of different socioeconomic levels. The prevalence of diabetes was similar to that in the developed countries. Tobacco use in women living in Santiago and Buenos Aires was among the world’s highest. Intima-media thickness and carotid plaque prevalences varied widely. |
| |
Keywords: | |
本文献已被 ScienceDirect PubMed 等数据库收录! |
|